Radiation Therapy + Chemotherapy for Stage T1 Bladder Cancer (UW 7684)
RTOG 0926 A Phase II Protocol For Patients With Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment By Radiation Therapy Concurrent With Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging.
Investigator: George Laramore, MD, PhD; Conditions: Bladder Cancer; Status: Recruiting; Study ID: NCT00981656
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma
Investigator: Evan Ya-Wen Yu, MD; Conditions: Urologic Neoplasms, Metastatic Bladder Cancer, Urinary Tract Neoplasms; Status: Closed; Study ID: NCT01454089
A Phase 1-2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Bladder Cancer
Investigator: Robert B. Montgomery, MD; Conditions: Bladder Cancer; Status: Recruiting; Study ID: NCT01938573